Biodel's formulation intended to provide faster onset of action than the currently available fast-acting insulin analogues. Nvo also thinks the need is there as you can tell from slide 12:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.